Health status of transgenic pigs expressing the human complement regulatory protein CD59

Xenotransplantation

Volumn 13, Issue 4, 2006, Pages 345-356

  Deppenmeier, Stefanie ^a,b   Bock, Oliver ^b   Mengel, Michael ^b   Niemann, Heiner ^c   Kues, Wilfried ^c   Lemme, Erika ^c   Wirth, Dagmar ^d   Wonigeit, Kurt ^b   Kreipe, Hans ^b  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c INSTITUT FÜR TIERZUCHT   (Germany)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Expression pattern; hCD59 transgenic pigs; Health status; Phenotype; Xenotransplantation

Indexed keywords

CD59 ANTIGEN; MESSENGER RNA; REGULATOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HEALTH STATUS; IMMUNOHISTOCHEMISTRY; MALE; MORPHOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TRANSGENIC ANIMAL; WILD TYPE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD59; FEMALE; HUMANS; MALE; ORGAN SPECIFICITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUS SCROFA; TISSUE ARRAY ANALYSIS; TRANSGENES;

EID: 33745062852     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2006.00317.x     Document Type: Article

References (37)

1. Galili U Rachmilewitz EA Peleg A Flechner I. A unique natural human IgG antibody with anti-α-galactosyl specificity. J Exp Med 1984 160 : 1519.
2. Galili U Clark MR Shohet SB Buehler J Macher BA. Evolutionary relationship between the natural anti-Gal antibody and the Galα1-3Gal epitopes in primates. Proc Natl Acad Sci USA 1987 84 : 1369.
3. Platt JL Fischel RJ Matas AJ et al. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991 52 : 214.
4. Rose AG Cooper DKC. Venular thrombosis is the key event in the pathogenesis of antibody-mediated cardiac rejection. Xenotransplantation 2000 7 : 31.
5. Kues WA Niemann H. The contribution of farm animals to human health. Trends Biotechnol 2004 22 : 286.
6. Davies A Simmons DL Hale G et al. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells. J Exp Med 1989 170 : 637.
7. Meri S Morgan BP Davies AR et al. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 1990 71 : 1.
8. Rollins SA Sims PJ. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. J Immunol 1990 144 : 3478.
9. Niemann H Kues WA. Transgenic livestock: premises and promises. Anim Reprod Sci 2000 60-61 : 277.
10. Fox MW. Genetic engineering biotechnology: animal welfare and environmental concerns. Appl Anim Behav Sci 1988 20 : 83.
11. Hughes BO Hughes GS Waddington D Appleby MC. Behavioural comparison of transgenic and control sheep: movement order, behaviour on pasture and in covered pens. J Anim Sci 1996 63 : 91.
12. Niemann H Halter R Carnwath JW et al. Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res 1999 8 : 237.
13. Van Reenen CG Meuwissen THE Hopster H et al. Transgenesis may affect farm animal welfare: a case for systemic risk assessment. J Anim Sci 2001 79 : 1763.
14. Pursel VG Pinkert CA Miller KF et al. Genetic engineering of livestock. Science 1989 244 : 1281.
15. Nottle MB Nagashima H Verma PJ et al. Production and analysis of transgenic pigs containing a metallothionein porcine growth hormone gene construct. In : Murray JD Anderson GB Oberbauer AM McGloughlin MM, eds. Transgenic Animals in Agriculture. New York, NY, USA : CABI Publ., 1999. 145 156.
16. Niemann H Wrenzycki C. Alterations of expression of developmentally important genes in preimplantation bovine embryos by in vitro culture conditions: implications for subsequent development. Theriogenology 2000 53 : 21.
17. Cibelli JB Stice SL Golueke PJ et al. Cloned transgenic calves produced from nonquiescent fetal fibroblasts. Science 1998 280 : 1256.
18. Hill JR Roussel AJ Cibelli JB et al. Clinical and pathologic features of cloned transgenic calves and features (13 case studies). Theriogenology 1999 51 : 1451.
19. Carter DB Lai L Park KW et al. Phenotyping of transgenic cloned piglets. Cloning Stem Cells 2002 4 : 131.
20. Park KW Cheong HT Lai L et al. Production of nuclear transfer-derived swine that express the enhanced green fluorescent protein. Anim Biotechnol 2001 12 : 173.
21. Lai L Kolber-Simonds D Park KW et al. Production of α-1,3- galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002 295 : 1089.
22. Niemann H Verhoeyen E Wonigeit K et al. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. Transplantation 2001 72 : 1898.
23. Kues WA Schwinzer R Wirth D et al. Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double transgenic pigs. FASEB J 2006 Express fj. 05-4515 fjev1.
24. Lehmann U Kreipe H. Real time PCR analysis of DNA and RNA extracted from formalin-fixed and paraffin-embedded biopsies. Methods 2001 25 : 409.
25. Bock O Kreipe H Lehmann U. One-step extraction of RNA from archival biopsies. Anal Biochem 2001 295 : 116.
26. Gruber AD Levine RA. In situ assessment of mRNA accessibility in heterogenous tissue samples using elongation factor-1α (EF-1α). Histochem Cell Biol 1997 107 : 411.
27. Von Wasielewski R Mengel M Wiese B et al. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002 118 : 675.
28. Mengel M Werner M Von Wasielewski R. Concentration dependent and adverse effects in immunohistochemistry using the tyramine amplification technique. Biochem J 1999 31 : 195.
29. Jubb KVF Kennedy PC Palmer N. Pathology of Domestic Animals, 4th edn, Vol. 2. San Diego, CA, USA : Academic Press, 1993.
30. Krakowka S Ellis JA McNeilly F et al. Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2). Vet Pathol 2001 38 : 31.
31. Boshart M Weber F Jahn G et al. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. Cell 1985 41 : 521.
32. Fodor WL Williams BL Matis LA et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention xenogeneic hyperacute organ reaction. Proc Natl Acad Sci USA 1994 91 : 11153.
33. Furth PA Hennighausen L Baker C Beatty B Woychick R. The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promotor in transgenic mice. Nucleic Acids Res 1991 19 : 6205.
34. McGrew MJ Sherman A Ellard FM et al. Efficient production of germline transgenic chickens using lentiviral vectors. EMBO Rep 2004 5 : 1.
35. Baskar JF Smith PP Nilaver G et al. The enhancer domain of the human cytomegalovirus major immediate-early Promotor determines cell type-specific expression in transgenic mice. J Virol 1996 70 : 3207.
36. Furth PA St Onge L Boger H et al. Temporal control of gene expression in transgenic mice by a tertracycline-responsive Promotor. Proc Natl Acad Sci USA 1994 91 : 9302.
37. Hofmann A Kessler B Ewerling S et al. Epigenetic regulation of lentiviral transgene vectors in a large animal model. Mol Ther 2006 13 : 59.